News & Comment

Filter By:

Article Type
Year
  • The PHYSIC trial reveals substantial variability in how people respond to four different classes of blood-pressure-lowering drugs — highlighting the need to personalize treatments.

    • Karen O’Leary
    Research Highlight
  • A new study provides the strongest support yet for abnormal α-synuclein as a diagnostic biomarker that shows up even in the prodromal phase — with immediate implications for trial design and therapeutic development.

    • Karen O’Leary
    Research Highlight
  • A one-time gene-editing therapy restored motor function and prolonged lifespan in mice, spurring further research to refine and optimize the approach for future clinical use.

    • Karen O’Leary
    Research Highlight
  • Using CAR T cells to treat solid tumors is notoriously challenging, but a new study shows impressive responses rates in children with high-risk neuroblastoma.

    • Karen O’Leary
    Research Highlight
  • An in vitro technique to drop a Y chromosome and duplicate an X chromosome could expand the reach of fertility treatments in the future, although translation to humans remains an open question.

    • Karen O’Leary
    Research Highlight
  • According to a randomized trial, home-based monitoring of complicated pregnancies could be a safe alternative to hospital admission.

    • Karen O’Leary
    Research Highlight
  • For patients with advanced, resectable melanoma, treatment with pembrolizumab before as well as after surgery led to improved outcomes — without additional toxicity.

    • Karen O’Leary
    Research Highlight
  • For people taking statins, inflammation contributes more to cardiovascular disease risk than residual cholesterol does — and could be targeted with adjunct therapy.

    • Karen O’Leary
    Research Highlight
  • Existing models for predicting the 10-year risk of stroke are less accurate for Black adults than for white adults, even with the addition of novel machine-learning algorithms.

    • Karen O’Leary
    Research Highlight
  • An antibody–drug conjugate showed impressive anti-cancer activity in selected patients with platinum-resistant ovarian cancer, and could become a new standard of care.

    • Karen O’Leary
    Research Highlight
  • Certain viruses — many of which have vaccines available — are linked to a significantly increased risk of neurodegenerative disease in the years following infection.

    • Karen O’Leary
    Research Highlight
  • Six supplements widely marketed as cholesterol-lowering agents performed poorly compared with a low-dose statin — with a similar safety profile.

    • Karen O’Leary
    Research Highlight
  • Despite concerns that bariatric surgery may increase patients’ risk of esophageal or gastric cancers, a large retrospective study offers reassurance that this is not the case.

    • Karen O’Leary
    Research Highlight